scholarly journals Severity of Plasmodium vivax Malaria in Karachi: a cross-sectional study

2012 ◽  
Vol 6 (09) ◽  
pp. 664-670 ◽  
Author(s):  
Amber Mehmood ◽  
Kiran Ejaz ◽  
Tauqeer Ahmed
Keyword(s):  
Plasmodium Vivax ◽  
Vivax Malaria ◽  
Tertiary Care ◽  
Cross Sectional Study ◽  
Care Hospital ◽  
Shock Index ◽  
Sectional Study ◽  
Cross Sectional ◽  
Number Of Patients ◽  
Plasmodium Vivax Malaria

Introduction: Plasmodium vivax malaria affects billions of people annually. This study aimed to note the presentations and complications and subsequently to identify the determinants of in-patient hospital care of P. vivax malaria patients presenting to a tertiary care hospital in Karachi, Pakistan. Severity of the shock was also assessed using a shock index. Methodology: This study descriptive cross-sectional study was conducted at the Emergency Department of Aga Khan University Hospital, Karachi. All adult patients with a positive P. vivax peripheral film and/or immunochromatography admitted through the department were studied during 2009. Data was entered and analyzed using SPSS version 16. Keeping the length of stay at a cut-off of 48 hours after admission, the independent Student-t test was applied. Level of significance was taken at 0.05. Results: A total of 97 patients were included in the study. Fever was the most common presentation. A significant number of patients had nonspecific complaints, but tachycardia, altered mental status, and adult respiratory distress syndrome were important findings. Mean shock index was 1 (SD 0.26). Common reasons for admission were thrombocytopenia and dehydration. Some patients were admitted for more than 48 hours. Complications included pneumonia and bleeding requiring platelet transfusion. Conclusion: This study highlights that the debilitating impact of P. vivax malaria remains high. Although the effects of severe vivax malaria can be contained through aggressive resuscitation and specific therapy, sensitivity and awareness of this complicated course must be highlighted among caregivers.

Platelet Alteration in Plasmodium vivax Malaria Patients in Thailand

2019 ◽  
pp. 1-6
Author(s):  
Mohammand Sami Hayat ◽  
Polrat Wilairatana ◽  
Noppadon Tangpukdee ◽  
Srivicha Krudsood ◽  
Nalinrat Wilairat ◽  
...  
Keyword(s):  
Global Health ◽  
Plasmodium Vivax ◽  
Vivax Malaria ◽  
Platelet Transfusion ◽  
Cross Sectional Study ◽  
Tropical Diseases ◽  
Sectional Study ◽  
Cross Sectional ◽  
Plasmodium Vivax Malaria ◽  
Global Health Problem

Introduction: Malaria remains a global health problem. Malaria is often linked to thrombocytopenia as well as other hematological variations. Objective: The aim of this study is to find the platelet changes in Plasmodium vivax malaria patients. This retrospective cross-sectional study included 204 malaria patients admitted to the Hospital for Tropical Diseases, Bangkok, Thailand. Results: Thrombocytopenia (<150x103/µl) was seen in 170(83.3%) patients with a mean (SD) of 101x103/µl (56.5). Mild (150x103/µl-50x103/µl), moderate (50x103/µl-20x103/µl) and severe (<20x103/µl) thrombocytopenia were seen in 141 (69.1%), 25 (12.2%) and 4 (2%) patients respectively. None of these patients with thrombocytopenia showed any sign of bleeding or required platelet transfusion. Conclusion: This study showed thrombocytopenia as a classic feature of vivax malaria presenting more than 80% of cases. In patients with profoundly low thrombocyte counts there was no manifestation of bleeding nor was any platelet transfusion required.

scholarly journals Study various clinical manifestations and biochemical parameter for liver dysfunction in association with Plasmodium vivax malaria

2020 ◽  
Vol 8 (8) ◽  
pp. 3035
Author(s):  
Bajranglal Banthia ◽  
Saad Mohammad Shakir
Keyword(s):  
Plasmodium Vivax ◽  
Liver Dysfunction ◽  
Vivax Malaria ◽  
Tertiary Care ◽  
Clinical Manifestations ◽  
Biochemical Parameter ◽  
Research Centre ◽  
Care Hospital ◽  
Number Of Patients ◽  
Plasmodium Vivax Malaria

Background: Malaria is a parasitic disease which is majorly caused by the bite of an infected Anopheles mosquito. It has been estimated that the most common type of malaria affecting the human race is known as Plasmodium vivax. Human malaria is a global burden with 3.4 billion people at risk over 91 endemic countries. According to the WHO, the involvement of liver dysfunction in Plasmodium vivax malaria is not an uncommon phenomenon. Aim of the research was to study various clinical manifestations and biochemical parameter for liver dysfunction in association with Plasmodium vivax malaria.Methods: It was an observational study carried out at Teerthanker Mahaveer Medical College and Research Centre, a tertiary care hospital situated in Moradabad for a period of 1 year (March 2017-Feb 2018). Total of 200 patients aged above 15 years, with either sex were part of it. All the patients having mixed malaria with dengue, pregnant women and the patients who did not give written consent for being a part of the study were excluded from the study. A detailed clinical examination was done, including all the hematological and biochemical examinations.Results: The results depicted that the number of male patients was 95, and the number of female patients was 105. The majority of the patients belonged to 15-30 years of age group. The major clinical features of the patients suffering from P. Vivax were fever and jaundice. The number of patients with serum bilirubin >3 mg/dl was 55.Conclusions: In light of the above results, it was evident that Plasmodium vivax has the capability of producing jaundice, hepatic dysfunction and anemia. The doctors must be very vigilant while treating the patients with Plasmodium vivax for any symptoms of jaundice as they are often misunderstood as hepatitis.

scholarly journals Needs assessment of resuscitative endovascular balloon occlusion of the aorta (REBOA) in patients with major haemorrhage: a cross-sectional study

2021 ◽  
pp. emermed-2020-210808
Author(s):  
Bård Neuenkirchen Godø ◽  
Jostein Rodseth Brede ◽  
Andreas Jorstad Krüger
Keyword(s):  
Needs Assessment ◽  
Tertiary Care Hospital ◽  
Tertiary Care ◽  
Cross Sectional Study ◽  
Balloon Occlusion ◽  
Care Hospital ◽  
Sectional Study ◽  
Cross Sectional ◽  
Number Of Patients ◽  
Endovascular Balloon Occlusion

BackgroundResuscitative endovascular balloon occlusion of the aorta (REBOA) can be used as an adjunct treatment in traumatic abdominopelvic haemorrhage, ruptured abdominal aortic aneurysms, postpartum haemorrhage (PPH), gastrointestinal bleeding and iatrogenic injuries during surgery. This needs assessment study aims to determine the number of patients eligible for REBOA in a typical Norwegian population.MethodsThis was a retrospective cross-sectional study based on data obtained from blood bank registries and the Norwegian Trauma Registry for the years 2017–2018. Patients who received ≥4 units of packed red blood cells (PRBCs) within 6 hours and met the anatomical criteria for REBOA or patients with relevant Abbreviated Injury Scale codes with concurrent hypotension or transfusion of ≥4 units of PRBCs within 6 hours were identified. A detailed two-step chart review was performed to identify potentially eligible REBOA candidates. Descriptive data were collected and compared between subgroups using non-parametric tests for statistical significance.ResultsOf 804 patients eligible for inclusion, 53 patients were regarded as potentially REBOA eligible (corresponding to 5.7 per 100 000 adult population/year). Of these, 19 actually received REBOA. Among the identified eligible patients, 44 (83%) had a non-traumatic aetiology. Forty-two patients (79%) were treated at a tertiary care hospital. Fourteen (78%) of the REBOA procedures were due to PPH.ConclusionThe number of patients potentially eligible for REBOA after haemorrhage is low, and most cases are non-traumatic. Most patients were treated at a tertiary care hospital. The exclusion of non-traumatic patients results in a substantial underestimation of the number of potentially REBOA-eligible patients.

Confidence toward vaccination as reported by parents of children admitted to a tertiary care hospital in Riyadh, Saudi Arabia: A cross sectional study

Vacunas ◽  
2020 ◽  
Vol 21 (2) ◽  
pp. 95-104 ◽  
Author(s):  
Y.M. AlGoraini ◽  
N.N. AlDujayn ◽  
M.A. AlRasheed ◽  
Y.E. Bashawri ◽  
S.S. Alsubaie ◽  
...  
Keyword(s):  
Saudi Arabia ◽  
Tertiary Care Hospital ◽  
Tertiary Care ◽  
Cross Sectional Study ◽  
Care Hospital ◽  
Sectional Study ◽  
Cross Sectional

A Cross-sectional Study of Undiagnosed Fever in a Rural Population at a Tertiary Care Hospital of West Bengal

2018 ◽  
Vol 4 (3) ◽  
Author(s):  
Nandini Chatterjee ◽  
Supratick Chakraborty ◽  
Mainak Mukhopadhyay ◽  
Sinjon Ghosh ◽  
Bikramjit Barkandaj ◽  
...  
Keyword(s):  
Rural Population ◽  
West Bengal ◽  
Tertiary Care Hospital ◽  
Tertiary Care ◽  
Cross Sectional Study ◽  
Care Hospital ◽  
Sectional Study ◽  
Cross Sectional

scholarly journals The pattern of thyroiditis in multiple sclerosis: a cross-sectional study in a tertiary care hospital in Egypt

2020 ◽  
Vol 32 (1) ◽  
Author(s):  
Nearmeen M. Rashad ◽  
Marwa G. Amer ◽  
Waleed M. Reda Ashour ◽  
Hassan M. Hassanin
Keyword(s):  
Multiple Sclerosis ◽  
Interferon Beta ◽  
Demyelinating Disease ◽  
Tertiary Care ◽  
Cross Sectional Study ◽  
Care Hospital ◽  
Sectional Study ◽  
Cmv Infection ◽  
Cross Sectional ◽  
Disease Modifying Drugs

Abstract Background Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system with varied clinical features. Disease-modifying drugs (DMDs) of MS associated with different types of thyroiditis. In this cross-sectional study, we aimed to assess the prevalence of thyroid dysfunction in MS and to investigate the association between DMDs and the risk of thyroiditis in MS. A cross-sectional study included 100 patients with relapsing-remitting multiple sclerosis (RRMS) in relapse, and the diagnosed was according to revised McDonald’s criteria 2010. Results Our results revealed that the prevalence of thyroiditis was 40%; autoimmune (34%) and infective (6%) among patients with RRMS in relapse and cerebellar symptoms were significantly higher in patients with thyroiditis compared to patients without thyroiditis. Regarding the association between DMDs and thyroiditis, the prevalence of patients treated with interferon-beta-1b was higher in MS patients with thyroiditis compared to MS patients without thyroiditis. However, the prevalence of patients treated with interferon-beta-1a was lower in MS patients with thyroiditis compared to MS patients without thyroiditis. In addition, we found CMV infection was more common in patients treated by interferon beta-1b and candida infection was common in patients treated by fingolimod. Conclusions Thyroiditis is commonly observed in patients with RRMS in relapse and higher prevalence of patients treated with interferon-beta-1b which is commonly associated with thyroiditis and CMV infection; however, candida thyroid infection was common in MS patients treated by fingolimod.

Sign in / Sign up

Export Citation Format

Share Document